Frontiers in Pharmacology | Neuropharmacology

Mini Review

Published on 24 Jun 2025

Research on the effects of GLP-1 receptor agonists in treating cognitive dysfunction and gait disorders in elderly patients with diabetes

in Neuropharmacology

Yang Yang
Lifeng Chen
Yanjun Zhang
Wenqian Fu
Dandan Liu
Tianyu Jiang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1607443

180 views

Original Research

Accepted on 23 Jun 2025

Ramipril and ketogenic diet response in cognitive dysfunction of insulin-resistant rats

in Neuropharmacology

Nancy Mahmoud Abdel Kareem
Shimaa Elshazly
May Abd El Fattah
Sawsan Zaitone
Thanaa Elmasry
Asmaa Saleh
Enas Abd El-Haleim

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1620139

Review

Published on 23 Jun 2025

Unveiling the therapeutic potential of natural products in Alzheimer’s disease: insights from in vitro, in vivo, and clinical studies

in Neuropharmacology

Nahida Aktary
Yerim Jeong
Seungji Oh
Yeju Shin
Yoonsoo Sung
Muntajin Rahman
Livia Ramos Santiago
Jinwon Choi
Han Gyeul Song
Fahrul Nurkolis

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1601712

506 views

Original Research

Accepted on 20 Jun 2025

Acute Pharmacological Effects of α-PVP in Humans: A Naturalistic Observational study

in Neuropharmacology

Georgina de la Rosa
Esther Papaseit Fontanet
Olga Hladun
Lourdes Poyatos
Dolly Andrea Caicedo
Martha Catalina Argote
Soraya Martin
Mireia Ventura
Nunzia La Maida
Annagiulia Di Trana

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1626692

Review

Accepted on 20 Jun 2025

Orexin-A and Motion Sickness: A Systematic Review of Animal Model Studies

in Neuropharmacology

Xu Cai
Long Zhao
Xin Wang
Jiahui Chen
Ying Yuan
Biao Gao
Yanli You

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1624080

Review

Accepted on 20 Jun 2025

Preclinical and Experimental Evidence of Salvianolic Acid B in the Treatment of Neurological Diseases

in Neuropharmacology

Shijun Bi
Shibing Liu
Kunyuan Zhu
Dandan Gao
Ligang Chen
Chunyong Yu
Guobiao Liang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1606146

Hypothesis and Theory

Accepted on 20 Jun 2025

The Antipsychotics Functional Index (AFI) in Schizophrenia

in Neuropharmacology

Gabriel-Cristian Marinescu
Petru Iulian Ifteni
Andreea Teodorescu
Radu Georgescu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1591763

Original Research

Published on 20 Jun 2025

Network pharmacology-based prediction and “gut microbiota-inflammation-brain axis” validation of the active ingredients and potential mechanisms of Plantagins Herba for treating diabetes-related cognitive dysfunction

in Neuropharmacology

Zhixuan Huang
Jian Liu
Hui Li
Yangwen Ai
Dongyue Zhou

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1601689

358 views

Original Research

Published on 20 Jun 2025

Age-specific effects of synthetic cannabinoids on cognitive function and hippocampal gene expression in mice: insights from behavioral and molecular correlates

in Neuropharmacology

Kaixi Li
Yuanyuan Chen
Yawen Xu
Yuan Pang
Yongli Bao
Simeng Zhang
Xuesong Shi
Jingzhi Ran
Yanling Qiao
Yizhao Xu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1618929

291 views

Review

Published on 19 Jun 2025

Plant-derived polyphenolic compounds for managing schizophrenia: mechanisms and therapeutic potential

in Neuropharmacology

Xiaolin Ji
Jianbo Chai
Sihan Zhao
Yonghou Zhao

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1605027

294 views

Original Research

Accepted on 18 Jun 2025

Preclinical Pharmacology of Alogabat: A Novel GABAA-α5 Positive Allosteric Modulator Targeting Neurodevelopmental Disorders with Impaired GABAA Signaling

in Neuropharmacology

Giuseppe Cecere
Theresa M Ballard
Frederic Knoflach
Michael Honer
Joerg F Hipp
Pilar Garcés
Thomas Mueggler
Basil Künnecke
Andreas Bruns
Eric P. Prinssen

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1626078

115 views

Review

Published on 18 Jun 2025

Therapeutic potential of natural products in ischemic stroke: targeting angiogenesis

in Neuropharmacology

WenQiang Li
E. Liu
YiHao Zhou
ZhiChao Liao
DongYan Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1579172

301 views

Correction

Published on 18 Jun 2025

Correction: Preventive strategies for reducing intraoperative awareness due to errors in anesthetic drug delivery systems: a narrative review

in Neuropharmacology

Qisheng Chen
Shixuan Peng
Wenjun Luo
Shuzhai Li
Zhiming Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1641124

218 views

Systematic Review

Published on 18 Jun 2025

Effectiveness and impact of intravenous magnesium sulfate in spinal surgery systematic review and meta-analysis

in Neuropharmacology

Zhaoguo Jin
Jianyong Zhao

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1624119

414 views

Original Research

Accepted on 17 Jun 2025

Kynurenine pathway as a possible link between ethanol exposure produced behavioral alterations and neuroinflammation

in Neuropharmacology

Leticia Gil de Biedma-Elduayen
Pablo Gimenez Gomez
Nuria Morales-Puerto
Rebeca Vidal Casado
Alvaro del Río García
Carlos Núñez de la Calle
Lluna Careaga Heres
Maria Dolores Gutiérrez López
Esther O’Shea
Maria Isabel Colado

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1628527

Original Research

Accepted on 17 Jun 2025

Exploration of the potential neurotransmitter or neuromodulator-like properties of harmine: Evidence from synthesis to synaptic modulation

in Neuropharmacology

Zhejun Xie
Ning Cao
Manlin Li
Hanxue Wang
Huida Guan
Xuemei Cheng
Changhong Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1588105